Cabaletta Bio Inc (CABA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,339 | -16,943 | -12,202 | N/A | N/A |
| Depreciation Amortization | 473 | 104 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 555 | 246 | 234 | N/A | N/A |
| Other Working Capital | 1,906 | -1,405 | -464 | N/A | N/A |
| Other Operating Activity | 3,635 | 1,953 | 7,771 | 0 | 0 |
| Operating Cash Flow | $-26,770 | $-16,045 | $-4,661 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -635 | -693 | N/A | N/A | N/A |
| Purchase Of Investment | -7,346 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-7,981 | $-693 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 12,535 | N/A | N/A |
| Common Stock Issued | -24 | 71,218 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 48,707 | 25,142 | 0 | 0 |
| Financing Cash Flow | $-24 | $119,925 | $37,677 | $N/A | $N/A |
| Beginning Cash Position | 136,204 | 33,017 | 1 | N/A | N/A |
| End Cash Position | 101,429 | 136,204 | 33,017 | N/A | N/A |
| Net Cash Flow | $-34,775 | $103,187 | $33,016 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,770 | -16,045 | -4,661 | N/A | N/A |
| Capital Expenditure | -635 | -693 | N/A | N/A | N/A |
| Free Cash Flow | -27,405 | -16,738 | -4,661 | 0 | 0 |